Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma

[1]  Sasha Colby,et al.  Projections of the Size and Composition of the U.S. Population: 2014 to 2060. Population Estimates and Projections. Current Population Reports. P25-1143. , 2015 .

[2]  G. Mckhann,et al.  RT-36ONCOLOGIC OUTCOME OF HISPANIC PATIENTS WITH GLIOBLASTOMA TREATED WITH RADIOTHERAPY , 2014 .

[3]  M. Gilbert,et al.  Advances in treating glioblastoma , 2014, F1000prime reports.

[4]  H. Shih,et al.  Underutilization of radiation therapy in patients with glioblastoma , 2014, Cancer.

[5]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[6]  Kimberly J. Johnson,et al.  Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. , 2012, Neuro-oncology.

[7]  P. Brown,et al.  Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme , 2012, Cancer.

[8]  Ameer L. Elaimy,et al.  Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis , 2012, World Journal of Surgical Oncology.

[9]  J. Tracy,et al.  Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. , 2012, Gynecologic oncology.

[10]  K. Houkin,et al.  [Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma]. , 2012, No shinkei geka. Neurological surgery.

[11]  Y. Kuo,et al.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis , 2012, Journal of Cancer Research and Clinical Oncology.

[12]  R. Weichselbaum,et al.  Improved survival time trends for glioblastoma using the SEER 17 population-based registries , 2012, Journal of Neuro-Oncology.

[13]  R. Dubrow,et al.  Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007 , 2011, BMC Cancer.

[14]  K. Kozak,et al.  Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. , 2009, Neuro-oncology.

[15]  W. Curry,et al.  Racial, ethnic and socioeconomic disparities in the treatment of brain tumors , 2009, Journal of Neuro-Oncology.

[16]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[17]  J. Dodge,et al.  Incidence of first primary central nervous system tumors in California, 2001–2005: children, adolescents and teens , 2009, Journal of Neuro-Oncology.

[18]  Gabriele Schackert,et al.  Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.

[19]  W. Curry,et al.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma , 2007, Journal of Neuro-Oncology.

[20]  Yan Liu,et al.  New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2006, Journal of the National Cancer Institute.

[21]  Craig C Earle,et al.  Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. , 2006, International journal of radiation oncology, biology, physics.

[22]  Timothy C Ryken,et al.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.

[23]  A. Verma.  MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .

[24]  P. Kvale,et al.  Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. , 2006, Chest.

[25]  S. Preston‐Martin,et al.  A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999 , 2005, Cancer.

[26]  K. Hess,et al.  Adult glioma incidence trends in the United States, 1977–2000 , 2004, Cancer.

[27]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[28]  A. Sloan,et al.  Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997. , 2003, Journal of neurosurgery.

[29]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[30]  Geetha Krishnan,et al.  Occupation and Adult Gliomas in the San Francisco Bay Area , 2003, Journal of occupational and environmental medicine.

[31]  G. Somes,et al.  Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. , 2002 .

[32]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[33]  Reto Meuli,et al.  Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[35]  M. Lopez-Gonzalez,et al.  Brain tumors in Mexico: characteristics and prognosis of glioblastoma. , 2000, Surgical neurology.

[36]  M. Prados,et al.  Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. , 1995, Neurosurgery.

[37]  D A Savitz,et al.  Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. , 1995, American journal of epidemiology.

[38]  Long-term survival in patients with glioblastoma multiforme. , 1993, Neurosurgery.

[39]  D. Nelson,et al.  Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. , 1993, International journal of radiation oncology, biology, physics.

[40]  N. Greig,et al.  Increasing annual incidence of primary malignant brain tumors in the elderly. , 1990, Journal of the National Cancer Institute.

[41]  S. Preston‐Martin.  Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. , 1989, Neuroepidemiology.

[42]  L. Salford,et al.  Ten-year survival among patients with supratentorial astrocytomas grade III and IV. , 1988, Journal of neurosurgery.

[43]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[44]  M. Brock,et al.  Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas , 1985, Clinical Neurology and Neurosurgery.

[45]  The glioblastoma multiforme in Georgia, 1977–1981 , 1985 .

[46]  M. Walker,et al.  An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. , 1979, International journal of radiation oncology, biology, physics.